Drug Information

Drug General Information
Drug ID
D01RXW
Former ID
DCL001250
Drug Name
Vaniprevir
Drug Type
Small molecular drug
Indication HCV infection [ICD9: 070.4, 070.5, 070.70; ICD10:B17.1, B18.2] Phase 2 [551141]
Company
Merck
Structure
Download
2D MOL

3D MOL
Formula
C38H55N5O9S
Canonical SMILES
CCC1CC1(C(=O)NS(=O)(=O)C2CC2)NC(=O)C3CC4CN3C(=O)C(NC(=O<br />)OCC(CCCCC5=C6CN(CC6=CC=C5)C(=O)O4)(C)C)C(C)(C)C
InChI
1S/C38H55N5O9S/c1-7-25-18-38(25,33(46)41-53(49,50)27-14-15-27)40-31(44)29-17-26-20-43(29)32(45)30(36(2,3)4)39-34(47)51-22-37(5,6)16-9-8-11-23-12-10-13-24-19-42(21-28(23)24)35(48)52-26/h10,12-13,25-27,29-30H,7-9,11,14-22H2,1-6H3,(H,39,47)(H,40,44)(H,41,46)/t25-,26-,29+,30-,38-/m1/s1
InChIKey
KUQWGLQLLVFLSM-ONAXAZCASA-N
PubChem Compound ID
24765256
PubChem Substance ID
49685239, 56176882, 123055412, 152258148, 160646985, 170484202, 172541650, 198949212, 198992951, 229295762, 246655712
Drug Resistance Mutation (DRM)
DRM DRM Info
Target and Pathway
Target(s) HIV protease Target Info Inhibitor [551141]
References
Ref 551141Clinical pipeline report, company report or official report of Merck (2011).
Ref 551141Clinical pipeline report, company report or official report of Merck (2011).

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.